Xi'an Janssen tackles TB problem

Pharma group launches activities to raise awareness of the disease

Xian Janssen Pharmaceutical Ltd, one of China's largest pharmaceutical joint ventures, launched a set of activities to help tackle tuberculosis and multidrug-resistant tuberculosis (MDR-TB) in China.

Through its initiative, Xian Janssen, a company under Johnson&Johnson, engaged in a range of activities to increase disease awareness among the public and improve patient care, to gather momentum for World TB Day, which was held on March 24.